Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News PICO IV and Liquivida partner to advance sterile CBD delivery in IV therapy, appoint Sam Tejada as brand spokesperson PICO IV partners with Liquivida to launch sterile CBD IV therapy, appointing Sam Tejada as spokesperson. Aims to expand ECS education and clinical adoption. bySoujanya RaviAugust 15, 2025